KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Change in Accured Expenses: 2009-2024

Historic Change in Accured Expenses for Incyte (INCY) over the last 16 years, with Dec 2024 value amounting to $278.9 million.

  • Incyte's Change in Accured Expenses fell 5.43% to $115.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$157.0 million, marking a year-over-year decrease of 159.15%. This contributed to the annual value of $278.9 million for FY2024, which is 20.95% up from last year.
  • Latest data reveals that Incyte reported Change in Accured Expenses of $278.9 million as of FY2024, which was up 20.95% from $230.6 million recorded in FY2023.
  • Incyte's Change in Accured Expenses' 5-year high stood at $278.9 million during FY2024, with a 5-year trough of $113.8 million in FY2020.
  • Over the past 3 years, Incyte's median Change in Accured Expenses value was $230.6 million (recorded in 2023), while the average stood at $243.2 million.
  • Data for Incyte's Change in Accured Expenses shows a peak YoY surged of 67.53% (in 2022) over the last 5 years.
  • Over the past 5 years, Incyte's Change in Accured Expenses (Yearly) stood at $113.8 million in 2020, then climbed by 15.46% to $131.4 million in 2021, then skyrocketed by 67.53% to $220.2 million in 2022, then climbed by 4.73% to $230.6 million in 2023, then increased by 20.95% to $278.9 million in 2024.